Cargando…
Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases
OBJECTIVES: Serum synaptic proteins levels may change with age‐related neurodegeneration, affecting their clinical implications as a disease biomarker. We aimed to investigate neuronal and astroglial markers in patients with multiple sclerosis (MS) and aquaporin‐4 antibody‐seropositive neuromyelitis...
Autores principales: | Lee, Eun‐Jae, Lim, Young‐Min, Kim, Seungmi, Choi, Lynkyung, Kim, Hyunjin, Kim, Keonwoo, Kim, Hye Weon, Lee, Ji Sung, Kim, Kwang‐Kuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317646/ https://www.ncbi.nlm.nih.gov/pubmed/32495489 http://dx.doi.org/10.1002/acn3.51070 |
Ejemplares similares
-
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
por: Kim, Hyunjin, et al.
Publicado: (2020) -
Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases
por: Kim, Hyo Jae, et al.
Publicado: (2023) -
Disease characteristics of idiopathic transverse myelitis with serum neuronal and astroglial damage biomarkers
por: Kim, Keon-Woo, et al.
Publicado: (2023) -
Serum proteins for monitoring and predicting visual function in patients with recent optic neuritis
por: Kim, Hyo Jae, et al.
Publicado: (2023) -
Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
por: Park, Hwan Tae, et al.
Publicado: (2019)